Our results revealed that the treatment of CML and CEL upregulates TET1 expression (Figures 5A, B), which indicates AGE and RAGE interactions may facilitate the elevation of TET1 level to mediate epigenetic modulation of RAGE. This evidence concerns the gene TET1 and chronic myelogenous leukemia, BCR-ABL1 positive.